Selective inhibition of cyclooxygenase-2 attenuates expression of inflammation-related genes in CNS injury.
O'Banion
M Kerry
MK
Department of Neurology, Department of Neurobiology & Anatomy, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642 USA.
Kyrkanides
Stephanos
S
Olschowka
John A
JA
D000818:Animals; D001930:Brain Injuries / Q000201:enzymology / Q000235:genetics* / Q000503:physiopathology / Q000517:prevention & control; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D017931:DNA Primers; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D006801:Humans; D007249:Inflammation / Q000209:etiology / Q000235:genetics* / Q000517:prevention & control; D007527:Isoenzymes / Q000378:metabolism*; D008297:Male; D008565:Membrane Proteins; D051379:Mice; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism*; D012333:RNA, Messenger / Q000235:genetics; D013119:Spinal Cord Injuries / Q000201:enzymology / Q000235:genetics* / Q000503:physiopathology / Q000517:prevention & control; D014158:Transcription, Genetic
D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D017931:DNA Primers; D007527:Isoenzymes; D008565:Membrane Proteins; D012333:RNA, Messenger; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases